Healthcare
Tuesday, September 20, 2016
BRIEF-Adamas announces results of Ease Lid 3
* Announces results of Ease Lid 3, a pivotal trial of ADS
5102 for the treatment of Levodopa-induced Dyskinesia (lid) in
parkinson's disease patients at the 4th world parkinson congress
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment